Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

NCT00768196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2010-12-07

No results posted yet for this study

Summary

The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Principal Investigators

  • Joon-Woo Bahn · AstraZeneca Korea

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Completion
2009-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768196 on ClinicalTrials.gov